Status and phase
Conditions
Treatments
About
A Phase 3 Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age of 19 or above
Inadequately controlled Essential hypertension at Screening
Drug naive or didn't take antihypertensive drug within 2 weeks prior to Visit 1
Taking antihypertensive drug but not controlled
Inadequately controlled after 4 weeks of Candesartan 16mg monotherapy
Ability to provide written informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
135 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal